Navigation Links
Passages Malibu Acknowledges the Growing Popularity of “Molly” Among Teens
Date:3/6/2013

Malibu, CA (PRWEB) March 06, 2013

Molly is the nickname of a new kind of designer drug that is being marketed as a still-legal alternative to MDMA, better known as ecstasy or X. Molly stands for “molecule,” is sold as a powder or pill, and remains legal in the US, despite bans in several European countries and Japan.

Molly sometimes refers to the “pure” form of MDMA which remains illegal. A recent sting operation at Tulane University intercepted 107 grams of Molly headed to a fraternity house. A search of that house revealed numerous other illicit drugs, including LSD, cocaine, DMT, and mushrooms. Trends suggest that despite the perception of Molly as a harmless drug, it is becoming a staple substance of the wider drug culture pharmacopeia.

Molly is often tied to the club scene and can result in psychotic episodes and/or extreme anxiety, requiring hospitalization.

The full chemical name of the drug is 3-Trifluoromethylphenylpiperazine (TFMPP) and is often mixed with benzylpiperazine (BZP) and then diluted or “cut” with plant food or baking soda. The resulting combination crudely mimics the effects of MDMA and occasionally leads to migraine headaches, muscle aches, nausea, and/or vomiting.

“Substances that have yet to be properly evaluated by the DEA have the strong potential for abuse,” says Pax Prentiss, CEO of the world-renowned Passages, “Especially among young people, who are still developing and might not recognize the potential threat to their health and wellbeing. We specialize in helping people with prescription drug addiction and illegal substances, we are honored to work with everyone who comes through our doors. If anyone is looking for a holistic method to overcome their addiction without using the 12-step method, we want them to be aware of the diverse options that Passages Malibu has available.”

At Passages Malibu - Addiction Ends Here™

About Passages Malibu and Passages Ventura:
Father and son team Chris and Pax Prentiss founded Passages Malibu in 2001. Its second location, Passages Ventura, first opened its doors in 2009. The two alcohol and drug addiction treatment centers offer an alternative to the 12 step/AA model of addiction treatment by utilizing a holistic program that focuses on the underlying issues of substance dependency, rather than attributing addiction to an incurable disease.

Both Passages Malibu and Passages Ventura accept insurance and each have earned the coveted Joint Commission (JCAHO) accreditation, which has only been given to 6% of the nation’s behavioral health treatment programs.

Passages Malibu was named the “Number 1 Treatment Center in the World” by Healthcare Global and one of the "Most Luxurious Places to Dry Out" by Forbes magazine. The co-founders are also authors of an acclaimed series of addiction treatment books, including their groundbreaking flagship title, The Alcoholism and Addiction Cure.

For general inquiries about treatment, contact: 866-233-1753.

For media inquiries, contact:
press(at)passagesmalibu(dot)com

Read the full story at http://www.prweb.com/releases/Passages-Rehab-Centers/Molly-designer-drug/prweb10479214.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chemical Bank Conducts Personal Finance Classes for Passages Program at Eagle Village
2. Passages Malibu Applauds Easier Access to Addiction Treatment Starting in 2014
3. Non 12 Step Addiction Rehab Pioneer Dr. A.R. Mohammad of Inspire Malibu Announces Campaign to Raise Awareness about Underage Drinking
4. Growing up as a neural stem cell: The importance of clinging together and then letting go
5. Slow-growing babies more likely in normal-weight women; Less common in obese pregnancies
6. Tiny Batteries Pose Growing Threat to Kids
7. Heart disease map of England highlights growing social inequality in older ages
8. DiscountFurnaceFilter.com is Recognized by Inc. 5000 for Nation’s Fastest-Growing Companies
9. Cloud Storage Market growing at CAGR of 40.2% to reach $46.8 Billion by 2018 - New Report by MarketsandMarkets
10. Activated Carbon Market Growing at CAGR of 11.1% to Reach $3 Billion by 2016 - New Report by MarketsandMarkets
11. Fuel Additives Market Growing at CAGR of 6% to Reach $6,401 Million by 2017 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: